The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline - PubMed (original) (raw)

The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline

Susan M Resnick et al. Clin Trials. 2004.

Abstract

The Women's Health Initiative Study of Cognitive Aging (WHISCA) was a two armed, randomized, placebo controlled, clinical trial designed to assess the efficacy of postmenopausal hormone therapy on age related changes in specific cognitive functions. WHISCA was an ancillary study to the Women's Health Initiative (WHI) and the WHI Memory Study (WHIMS) and enrolled 2302 women aged 66 to 84 years (mean 73.9; standard deviation 3.8) who did not meet criteria for dementia. Women were randomly assigned by the WHI to hormone treatment (unopposed conjugated estrogens (CEE) 0.625 mg/day if they were without a uterus; CEE combined with medroxyprogesterone acetate (MPA) 2.5 mg/day otherwise) or placebo for an average of three years before the first WHISCA assessment. WHISCA investigated the effects of hormone therapy on rates of change over time in memory, other aspects of cognition (language, attention, spatial ability), motor function, and mood. In this paper, we present the study rationale and design, including specific cognitive measures, and the challenges of incorporating WHISCA into an ongoing randomized trial. WHISCA provided a unique opportunity to investigate the potential of hormone therapy to modify age related changes in specific cognitive functions. WHISCA also demonstrated the feasibility of adding a detailed cognitive assessment into an ongoing clinical trial to address an important issue in women's health, despite the challenges of maintaining the integrity of the parent studies, ensuring high retention, and achieving high quality assurance across sites.

PubMed Disclaimer

Cited by

Postmenopausal hormone therapy and cognition.
McCarrey AC, Resnick SM. McCarrey AC, et al. Horm Behav. 2015 Aug;74:167-72. doi: 10.1016/j.yhbeh.2015.04.018. Epub 2015 Apr 30. Horm Behav. 2015. PMID: 25935728 Free PMC article. Review.
Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy.
Resnick SM, Espeland MA, An Y, Maki PM, Coker LH, Jackson R, Stefanick ML, Wallace R, Rapp SR; Women's Health Initiative Study of Cognitive Aging Investigators. Resnick SM, et al. J Clin Endocrinol Metab. 2009 Nov;94(11):4152-61. doi: 10.1210/jc.2009-1340. Epub 2009 Oct 22. J Clin Endocrinol Metab. 2009. PMID: 19850684 Free PMC article. Clinical Trial.
Enrollment in a brain magnetic resonance study: results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI).
Jaramillo SA, Felton D, Andrews L, Desiderio L, Hallarn RK, Jackson SD, Coker LH, Robinson JG, Ockene JK, Espeland MA; Women's Health Initiative Memory Study Research Group. Jaramillo SA, et al. Acad Radiol. 2007 May;14(5):603-12. doi: 10.1016/j.acra.2007.02.001. Acad Radiol. 2007. PMID: 17434074 Free PMC article.
General and domain-specific cognitive reserve, mild cognitive impairment, and dementia risk in older women.
Petkus AJ, Resnick SM, Rapp SR, Espeland MA, Gatz M, Widaman KF, Wang X, Younan D, Casanova R, Chui H, Barnard RT, Gaussoin S, Goveas JS, Hayden KM, Henderson VW, Sachs BC, Saldana S, Shadyab AH, Shumaker SA, Chen JC. Petkus AJ, et al. Alzheimers Dement (N Y). 2019 Apr 10;5:118-128. doi: 10.1016/j.trci.2019.02.003. eCollection 2019. Alzheimers Dement (N Y). 2019. PMID: 31011622 Free PMC article.
Intraindividual variability in domain-specific cognition and risk of mild cognitive impairment and dementia.
Vaughan L, Leng I, Dagenbach D, Resnick SM, Rapp SR, Jennings JM, Brunner RL, Simpson SL, Beavers DP, Coker LH, Gaussoin SA, Sink KM, Espeland MA. Vaughan L, et al. Curr Gerontol Geriatr Res. 2013;2013:495793. doi: 10.1155/2013/495793. Epub 2013 Dec 22. Curr Gerontol Geriatr Res. 2013. PMID: 24454359 Free PMC article.

The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline - PubMed (original) (raw)